Deals & Cases

Homburger advised BIOBank in its acquisition of Neutromedics AG

On January 7, 2020, NewAlpha Asset Management and Capital Croissance announced that BIOBank, a French human origin bone bank, acquired Neutromedics AG, a Swiss distributor of orthobiologics and orthopedic implants. BIOBank, a portfolio company of the growth equity fund NewAlpha Verto and of a fund managed by Capital Croissance, accelerates its international development with this first external growth transaction.

The Homburger team advising BIOBank in this transaction was led by partner Daniel Hasler (Corporate / M&A) and included associate Margrit Marti (Corporate / M&A), partner Franz Hoffet and associate Yves Bianchi (both Competition), counsel Peter Müller (Tax), associates Aliénor de Dardel (Employment and Executive Compensation) and Andrea Ziswiler (Banking and Finance) as well as junior associate Gregor Schifferle (Corporate / M&A).